Cogent Biosciences
Stock Forecast, Prediction & Price Target
Cogent Biosciences Financial Estimates
Cogent Biosciences Revenue Estimates
Cogent Biosciences EBITDA Estimates
Cogent Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $1.06M Low: $22.26K High: $2.09M avg. 0% | Avg: $75.16M Low: $1.57M High: $148.75M avg. 6990.40% | Avg: $276.69M Low: $5.81M High: $547.58M avg. 268.12% | Avg: $528.92M Low: $11.10M High: $1.04B avg. 91.15% |
Net Income
% change YoY
| $-71.80M N/A | $-132.64M -84.72% | $-192.41M -45.05% | Avg: $-236.84M Low: $-230.21M High: $-115.50M avg. -23.09% | Avg: $-172.42M Low: $-204.72M High: $-67.70M avg. 27.19% | Avg: $-34.09M Low: $-77.48M High: $9.29M avg. 80.22% | Avg: $109.13M Low: $-29.76M High: $248.02M avg. 420.09% |
EBITDA
% change YoY
| $-75.40M N/A | $-147.83M -96.06% | $-205.86M -39.24% | Avg: $212.01K Low: $4.45K High: $419.58K avg. 100.10% | Avg: $15.03M Low: $315.67K High: $29.75M avg. 6990.43% | Avg: $55.33M Low: $1.16M High: $109.51M avg. 268.12% | Avg: $105.78M Low: $2.22M High: $209.35M avg. 91.15% |
EPS
% change YoY
| -$1.85 N/A | -$2.26 -22.16% | -$2.42 -7.07% | Avg: -$2.25 Low: -$2.89 High: -$1.45 avg. 7.18% | Avg: -$1.52 Low: -$2.57 High: -$0.85 avg. 32.35% | Avg: -$0.43 Low: -$0.97 High: $0.12 avg. 71.83% | Avg: $1.37 Low: -$0.37 High: $3.11 avg. 420.09% |
Operating Expenses
% change YoY
| $75.55M N/A | $147.83M 95.68% | $208.13M 40.78% | Avg: $1.20M Low: $25.38K High: $2.39M avg. -99.41% | Avg: $85.70M Low: $1.79M High: $169.60M avg. 6990.40% | Avg: $315.48M Low: $6.62M High: $624.35M avg. 268.12% | Avg: $603.07M Low: $12.66M High: $1.19B avg. 91.15% |
FAQ
What is Cogent Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 126.10% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -230.21M, average is -236.84M and high is -115.50M.
What is Cogent Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1837.42% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $22.26K, average is $1.06M and high is $2.09M.
What is Cogent Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 132.86% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$2.89, average is -$2.25 and high is $-1.45.
What is the best performing analyst?
In the last twelve months analysts have been covering Cogent Biosciences stock. The most successful analyst is Kelly Shi.